A non-functioning pituitary adenoma initially mimicking a microprolactinoma: The case for long-term follow-up of patients with mild hyperprolactinemia?

[1]  A. Franzin,et al.  Endocrine inactive and gonadotroph adenomas: diagnosis and management , 2001, Journal of Neuro-Oncology.

[2]  M. Losa,et al.  Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome. , 2002, The Journal of clinical endocrinology and metabolism.

[3]  Brenda J. Crowe,et al.  Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? , 2002, The Journal of clinical endocrinology and metabolism.

[4]  A. Colao,et al.  Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin‐secreting and clinically non‐functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I‐methoxybenzamide , 2000, Clinical endocrinology.

[5]  S. Wardlaw,et al.  Diagnosis and Treatment of Pituitary Tumors , 1999 .

[6]  M. Molitch.  Medical treatment of prolactinomas. , 1999, Endocrinology and metabolism clinics of North America.

[7]  D. Hinton,et al.  Excessively high prolactin level in a patient with a nonprolactin-secreting adenoma. Case report. , 1998, Journal of neurosurgery.

[8]  M. Arosio,et al.  Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients , 1997, Journal of endocrinological investigation.

[9]  E. Laws,et al.  Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels. , 1994, Neurosurgery.

[10]  A. Paracchi,et al.  Cabergoline in the long-term therapy of hyperprolactinemic disorders. , 1992, Acta endocrinologica.

[11]  M. Scanlon,et al.  Dopamine agonists and pituitary tumor shrinkage. , 1992, Endocrine reviews.

[12]  S. Lamberts,et al.  Long‐term treatment with the dopamine agonist CV 205–502 of patients with a clinically non‐functioning, gonadotroph, or α‐subunit secreting pituitary adenoma , 1992, Clinical endocrinology.